XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Common Stock and Stock-Based Awards Plans
6 Months Ended
Jun. 30, 2020
Common Stock and Stock-Based Awards Plans  
Common Stock and Stock-Based Awards Plans

Note 8 – Common Stock and Stock-Based Awards Plans

Dividends

The Company began declaring and paying quarterly dividends during the first quarter of 2018. For the six months ended June 30, 2020, cash dividends paid totaled $11.4 million. On June 15, 2020, the Company declared a quarterly cash dividend of $0.16 per share of the Company’s common stock to shareholders of record as of June 30, 2020. The dividend in the aggregate amount of $5.8 million was paid on July 14, 2020. The Company’s future dividend policy is subject to the Company’s compliance with applicable law, and depending on, among other things, the Company’s results of operations, financial condition, level of indebtedness, capital requirements, contractual restrictions, restrictions in the Company’s debt agreements, and other factors that the Board of Directors may deem relevant, including the impact of the COVID-19 pandemic. Dividend payments are not mandatory or guaranteed; there can be no assurance that the Company will continue to pay a dividend in the future.

 

Share Repurchase Authorization

On February 19, 2020, the Board of Directors authorized a $150 million increase to its existing stock repurchase program. On October 26, 2018, the Board of Directors authorized the repurchase of $100 million of the Company’s common stock in addition to the $250 million previously approved on March 6, 2018. As of June 30, 2020, the Company had an aggregate $210.1 million remaining under its stock repurchase program.

Stock-Based Compensation

The Company’s 2019 Omnibus Incentive Compensation Plan (the 2019 Plan) authorizes the Company, upon approval of the Compensation Committee of the Board of Directors, to grant a variety of awards, including stock options, restricted shares and restricted stock units (both time-based and performance-based) and other forms of equity awards, or any combination thereof, to any director, officer, employee or consultant (including any prospective director, officer, employee or consultant) of the Company. Stock options (which have not been awarded since 2015) are granted to employees with an exercise price equal to the market price of the Company’s common stock on the date of grant, generally vest over a four-year period from the date of grant and have a term of 10 years. Time-based restricted stock units granted to employees generally vest over a four-year period from the date of grant, subject to the continued employment of the employee by the Company. Performance-based restricted stock units generally vest over a three-year performance cycle, which includes the year of the grant, and are based upon the Company’s achievement of specified performance metrics. Awards under the 2019 Plan to non-employee directors

have been in the form of restricted stock units, which vest in equal annual installments over a one-year period, starting on the grant date.

 

As of June 30, 2020, 2.7 million additional common shares were available for issuance under the Company’s 2019 Plan.

 

All share-based payments to employees, including grants of employee stock options, are recognized in the financial statements based on their grant date fair values. The total compensation cost recognized for stock-based awards was $3.3 million and $6.0 million for the three and six months ended June 30, 2020, respectively, and $2.9 million and $5.7 million for the three and six months ended June 30, 2019, respectively. The total income tax benefit recognized in the Condensed Consolidated Statements of Income (Loss) for stock-based awards was $0.8 million and $1.4 million for the three and six months ended June 30, 2020, respectively, and $0.7 million and $1.4 million for the three and six months ended June 30, 2019, respectively. Awards of restricted stock units and performance-based restricted stock units are valued at the closing market price of the Company’s common stock on the date of grant. For performance-based restricted stock units, compensation expense is based on the probability that the performance goals will be achieved, which is monitored by management throughout the requisite service period. When it becomes probable, based on the Company’s expectation of performance during the measurement period, that more or less than the previous estimate of the awarded shares will vest, an adjustment to stock-based compensation expense is recognized as a change in accounting estimate.

 

As of June 30, 2020, the unrecognized compensation cost and remaining weighted-average amortization period related to stock-based awards were as follows:

 

 

 

 

 

 

Performance-

 

 

 

 

Time-based

 

based

 

 

 

 

Restricted

 

Restricted

 

 

 

 

Stock

 

Stock

(in thousands, except remaining period data)

 

 

 

Units

 

Units(1)

Unrecognized compensation cost

 

 

 

$ 25,414

 

$ 6,296

Remaining weighted-average

 

 

 

 

 

 

 

 

amortization period

 

 

 

2.7 years

 

2 years

 

 

 

 

 

 

 

 

 

(1) Based on the probable achievement of the performance goals identified in each award.

The total cash received by the Company as a result of stock option exercises for the six months ended June 30, 2020 and 2019 was approximately $0.4 million and $0.7 million, respectively. The actual tax benefit realized as a result of stock option exercises and the vesting of other share-based awards during the six months ended June 30, 2020 and 2019 was $1.7 million and $1.6 million, respectively. For the six months ended June 30, 2020 and 2019, the total intrinsic value of stock options exercised was $0.1 million and $0.2 million, respectively.The Company awarded performance-based restricted stock units to employees during the six months ended June 30, 2020 and 2019. The number of performance-based restricted stock units that will ultimately be earned will not be determined until the end of the corresponding performance periods, and may vary from as low as zero to as high as 2.5 times the target number depending on the level of achievement of certain performance goals. The level of achievement of these goals is based upon the financial results of the Company for the last full calendar year within the performance period. The performance goals consist of certain levels of achievement using the following financial metrics: revenue, operating income margin, and return on invested capital. If the performance goals are not met based on the Company’s financial results, the applicable performance-based restricted stock units will not vest and will be forfeited. Shares subject to forfeited performance-based restricted stock units will be available for issuance under the Company’s 2019 Plan.The following table summarizes activities relating to the Company’s stock options:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Weighted-

 

Average

 

Aggregate

 

 

Number of

 

Average

 

Remaining

 

Intrinsic

 

 

Options

 

Exercise

 

Contractual

 

Value

 

 

(in thousands)

 

Price

 

Term (Years)

 

(in thousands)

Outstanding as of December 31, 2019

 

270

 

$20.02

 

 

 

 

Exercised

 

(20)

 

22.74

 

 

 

 

Outstanding and exercisable as of June 30, 2020

 

250

 

$19.80

 

2.91

 

$ 621

The aggregate intrinsic value in the table above is before income taxes and is calculated as the difference between the exercise price of the underlying options and the Company’s closing stock price as of the last business day of the period ended June 30, 2020 for options that had exercise prices that were below the closing price.The following table summarizes the activities related to the Company’s time-based restricted stock units:

 

 

 

 

 

Weighted-

 

 

Number of

 

 

Average

 

 

Units

 

 

Grant Date

 

 

(in thousands)

 

 

Fair Value

Non-vested awards outstanding as of December 31, 2019

 

893

 

 

$28.06

Granted

 

525

 

 

26.61

Vested

 

(283)

 

 

27.56

Forfeited

 

(41)

 

 

28.56

Non-vested awards outstanding as of June 30, 2020

 

1,094

 

 

$27.47

The following table summarizes the activities related to the Company’s performance-based restricted stock units:

 

 

 

 

 

 

Weighted-

 

 

 

Number of

 

 

Average

 

 

 

Units

 

 

Grant Date

 

 

 

(in thousands)

 

 

Fair Value

Non-vested awards outstanding as of December 31, 2019

 

 

384

 

 

$28.89

Granted (1)

 

 

165

 

 

28.02

Forfeited

 

 

(181)

 

 

30.04

Non-vested awards outstanding as of June 30, 2020

 

 

368

 

 

$27.93

(1) Represents target number of units that can vest based on the achievement of the performance goals.